152 related articles for article (PubMed ID: 2328776)
1. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound.
Levi-Schaffer F; Kupietzky A
Exp Cell Res; 1990 May; 188(1):42-9. PubMed ID: 2328776
[TBL] [Abstract][Full Text] [Related]
2. The role of mast cell-derived histamine in the closure of an in vitro wound.
Kupietzky A; Levi-Schaffer F
Inflamm Res; 1996 Apr; 45(4):176-80. PubMed ID: 8741007
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
[TBL] [Abstract][Full Text] [Related]
4. In vitro regeneration of activated rat peritoneal mast cells cocultured with 3T3 fibroblasts.
Levi-Schaffer F; Riesel N
Cell Immunol; 1989 Mar; 119(1):30-40. PubMed ID: 2920396
[TBL] [Abstract][Full Text] [Related]
5. Effects of interleukins on connective tissue type mast cells co-cultured with fibroblasts.
Levi-Schaffer F; Segal V; Shalit M
Immunology; 1991 Feb; 72(2):174-80. PubMed ID: 2016117
[TBL] [Abstract][Full Text] [Related]
6. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro.
Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Bloes WF; Stevens RL
J Immunol; 1985 Nov; 135(5):3454-62. PubMed ID: 2413121
[TBL] [Abstract][Full Text] [Related]
7. Activated mast cells are fibrogenic for 3T3 fibroblasts.
Levi-Schaffer F; Rubinchik E
J Invest Dermatol; 1995 Jun; 104(6):999-1003. PubMed ID: 7769271
[TBL] [Abstract][Full Text] [Related]
8. Thymus and activation-regulated chemokine (TARC)/CC chemokine ligand (CCL) 17 accelerates wound healing by enhancing fibroblast migration.
Kato T; Saeki H; Tsunemi Y; Shibata S; Tamaki K; Sato S
Exp Dermatol; 2011 Aug; 20(8):669-74. PubMed ID: 21521373
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 inhibits 3T3 fibroblast proliferation.
Rubinchik E; Levi-Schaffer F
Life Sci; 1996; 58(18):1509-17. PubMed ID: 8649180
[TBL] [Abstract][Full Text] [Related]
10. Rat mast cells communicate with fibroblasts via gap junction intercellular communications.
Au SR; Au K; Saggers GC; Karne N; Ehrlich HP
J Cell Biochem; 2007 Apr; 100(5):1170-7. PubMed ID: 17063481
[TBL] [Abstract][Full Text] [Related]
11. Unresponsiveness of rat peritoneal mast cells to immunologic reactivation.
Levi-Schaffer F; Gare M; Shalit M
J Immunol; 1990 Nov; 145(10):3418-24. PubMed ID: 1700010
[TBL] [Abstract][Full Text] [Related]
12. Long-term cultures of mast cells: a new model for studying the allergic response.
Levi-Schaffer F; Shalit M
Pharmacol Res; 1991 Dec; 24(4):307-17. PubMed ID: 1725209
[TBL] [Abstract][Full Text] [Related]
13. Mast cells and fibroblasts: two interacting cells.
Rubinchik E; Levi-Schaffer F
Int J Clin Lab Res; 1994; 24(3):139-42. PubMed ID: 7819593
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids inhibit proliferation and adhesion of the IL-3-dependent mast cell line, MC/9, to NIH/3T3 fibroblasts, with an accompanying decrease in IL-3 receptor expression.
Sakai H; Toyota N; Ito F; Takahashi H; Hashimoto Y; Iizuka H
Arch Dermatol Res; 1999 Apr; 291(4):224-31. PubMed ID: 10335920
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived cultured mast cells and peritoneal mast cells as targets of a growth activity secreted by BALB/3T3 fibroblasts.
Jozaki K; Kuriu A; Hirota S; Onoue H; Ebi Y; Adachi S; Ma JY; Tarui S; Kitamura Y
Exp Hematol; 1991 Mar; 19(3):185-90. PubMed ID: 1847337
[TBL] [Abstract][Full Text] [Related]
16. Effects of prolonged incubation of rat peritoneal mast cells with compound 48/80.
Levi-Schaffer F; Riesel-Yaron N
Eur J Immunol; 1990 Dec; 20(12):2609-13. PubMed ID: 1702718
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
[TBL] [Abstract][Full Text] [Related]
18. Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.
Nagler A; Segal V; Slavin S; Levi-Schaffer F
Clin Exp Immunol; 1995 Jun; 100(3):529-35. PubMed ID: 7539727
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the growth rate of mouse fibroblasts by IL-3-activated mouse bone marrow-derived mast cells.
Dayton ET; Caulfield JP; Hein A; Austen KF; Stevens RL
J Immunol; 1989 Jun; 142(12):4307-13. PubMed ID: 2786027
[TBL] [Abstract][Full Text] [Related]
20. The mast cell-committed progenitor. I. Description of a cell capable of IL-3-independent proliferation and differentiation without contact with fibroblasts.
Jarboe DL; Marshall JS; Randolph TR; Kukolja A; Huff TF
J Immunol; 1989 Apr; 142(7):2405-17. PubMed ID: 2784462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
